Outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy with and without diaphragmatic resection in patients with peritoneal …
Background Diaphragmatic resection (DR) is often required during cytoreductive
surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) to achieve complete …
surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) to achieve complete …
Diaphragmatic peritonectomy and full-thickness resection in CRS/HIPEC may allow higher completeness of cytoreduction rates with a low rate of respiratory …
A Craus-Miguel, JJ Segura-Sampedro… - Annals of Surgical …, 2021 - Springer
Background Cytoreductive surgery (CRS) provides a survival benefit when achieved without
residual disease. As diaphragm is frequently affected in peritoneal malignancies, complete …
residual disease. As diaphragm is frequently affected in peritoneal malignancies, complete …
Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience
F Carboni, O Federici, S Zazza, I Sperduti… - European Journal of …, 2021 - Elsevier
Introduction Complete cytoreductive surgery with hyperthermic intraperitoneal
chemotherapy is an effective treatment for improving prognosis of selected patients with …
chemotherapy is an effective treatment for improving prognosis of selected patients with …